Comparative Analysis of Tenecteplase versus Alteplase in Acute Ischemic Stroke: A Multicentric Observational Study from Eastern India
Background: Tenecteplase is used as an alternative to alteplase and is considered noninferior for thrombolysis in acute ischemic stroke. Objectives: To compare the effectiveness and adverse effects of tenecteplase and alteplase in the real-world management of acute ischemic stroke. Materials and Met...
| Published in: | Annals of Indian Academy of Neurology |
|---|---|
| Main Authors: | Arpan Dutta, Subhadeep Gupta, Uddalak Chakraborty, Chayan Mondal, Soumozit Banerjee, Deep Das, Sanat K. Jatua, Susanta Chakrabarty, Samiran Misra, Jishnu Bhattacharya, Samir K. Datta, Somnath Ghosh, Debasish Sanyal, Arnab Sarkar, Biman K. Ray |
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-05-01
|
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/aian.aian_59_24 |
Similar Items
Tenecteplase compared to alteplase in real-world outcome: A Swedish Stroke Register study
by: Mikael Skärlund, et al.
Published: (2024-10-01)
by: Mikael Skärlund, et al.
Published: (2024-10-01)
CLINICAL RESULTS OF THROMBOLYTIC THERAPY WITH ALTEPLASE AND TENECTEPLASE IN PATIENTS WITH MYOCARDIAL INFARCTION
by: L. A. Bondarenko, et al.
Published: (2015-12-01)
by: L. A. Bondarenko, et al.
Published: (2015-12-01)
Comprehensive Review of Tenecteplase for Thrombolysis in Acute Ischemic Stroke
by: Liyuan Wang, et al.
Published: (2024-05-01)
by: Liyuan Wang, et al.
Published: (2024-05-01)
Tenecteplase and alteplase for thrombolysis of acute ischemic stroke within 4.5 hours: An efficacy and safety study
by: Nikita Dhar, et al.
Published: (2022-01-01)
by: Nikita Dhar, et al.
Published: (2022-01-01)
Comparative effectiveness and safety of tenecteplase versus alteplase for intravenous thrombolysis in acute ischemic stroke: a retrospective study
by: Weili Zhao, et al.
Published: (2025-10-01)
by: Weili Zhao, et al.
Published: (2025-10-01)
Tenecteplase is here: navigating the shift of a stroke thrombolytic in the United States prior to FDA approval: a mini-review on rationale, barriers, and pathways
by: Julian M. Burwell, et al.
Published: (2025-04-01)
by: Julian M. Burwell, et al.
Published: (2025-04-01)
Evaluating the Safety of Tenecteplase Versus Alteplase for Acute Ischemic Stroke
by: Salma Guerrero Miranda, et al.
Published: (2025-08-01)
by: Salma Guerrero Miranda, et al.
Published: (2025-08-01)
Safety of tenecteplase vs. alteplase in telestroke: a large multistate experience (STAT)
by: Morgan Figurelle, et al.
Published: (2025-01-01)
by: Morgan Figurelle, et al.
Published: (2025-01-01)
Alteplase vs. Tenecteplase: An In-depth Analysis of Their Relative Effectiveness in Treating Acute Ischemic Stroke
by: Muhammad Junaid Azhar, et al.
Published: (2024-10-01)
by: Muhammad Junaid Azhar, et al.
Published: (2024-10-01)
Tenecteplase versus alteplase for the treatment of acute ischemic stroke: a meta-analysis of randomized controlled trials
by: Jian Huang, et al.
Published: (2024-12-01)
by: Jian Huang, et al.
Published: (2024-12-01)
Tenecteplase Versus Alteplase in Medium Vessel Occlusion Ischemic Stroke: A Secondary Analysis of the Alteplase Compared to Tenecteplase Randomized Trial
by: Fouzi Bala, et al.
Published: (2024-05-01)
by: Fouzi Bala, et al.
Published: (2024-05-01)
Tenecteplase versus alteplase in patients with acute ischemic stroke: an updated systematic review and meta-analysis
by: Abdelmonam M. Hagag, et al.
Published: (2025-08-01)
by: Abdelmonam M. Hagag, et al.
Published: (2025-08-01)
Efficacy and Safety of Intravenous Tenecteplase Versus Alteplase in Treating Acute Ischemic Stroke With Diabetes and Admission Hyperglycemia
by: Huihui Liu, et al.
Published: (2024-10-01)
by: Huihui Liu, et al.
Published: (2024-10-01)
Tenecteplase vs. alteplase for treatment of acute ischemic stroke: A systematic review and meta-analysis of randomized trials
by: Hassan Kobeissi, et al.
Published: (2023-01-01)
by: Hassan Kobeissi, et al.
Published: (2023-01-01)
Implementation of a Tenecteplase Protocol for Treatment of Acute Ischemic Stroke in a Health System
by: Alexis Pace, et al.
Published: (2024-04-01)
by: Alexis Pace, et al.
Published: (2024-04-01)
Tenecteplase Versus Alteplase in Acute Ischemic Stroke in Chinese Patients: Protocol for the ORIGINAL Study
by: Xia Meng, et al.
Published: (2024-07-01)
by: Xia Meng, et al.
Published: (2024-07-01)
Tenecteplase vs alteplase as bridging thrombectomy in ischemic stroke patients: a systematic review and meta analysis
by: Salim Harris, et al.
Published: (2025-08-01)
by: Salim Harris, et al.
Published: (2025-08-01)
Real-world data of tenecteplase vs. alteplase in the treatment of acute ischemic stroke: a single-center analysis
by: Yu Yao, et al.
Published: (2024-04-01)
by: Yu Yao, et al.
Published: (2024-04-01)
Switch to tenecteplase for intravenous thrombolysis in stroke patients: experience from a German high-volume stroke center
by: Alexander Sekita, et al.
Published: (2025-05-01)
by: Alexander Sekita, et al.
Published: (2025-05-01)
Tenecteplase versus alteplase for intravenous thrombolysis of acute ischemic stroke patients with large-vessel occlusion: a systematic review and meta-analysis
by: Beibei Yao, et al.
Published: (2025-03-01)
by: Beibei Yao, et al.
Published: (2025-03-01)
Efficacy and Safety of Intravenous Thrombolysis Beyond 4.5 Hours in Ischemic Stroke: A Systematic Review and Meta-Analysis
by: Muhammad Ahmad, et al.
Published: (2025-07-01)
by: Muhammad Ahmad, et al.
Published: (2025-07-01)
The efficacy and safety of tenecteplase compared with alteplase in adult patients with acute ischemic stroke: an updated systematic review and meta-analysis of ten randomized controlled trials
by: Karthikeyan Chinniah, et al.
Published: (2023-10-01)
by: Karthikeyan Chinniah, et al.
Published: (2023-10-01)
Tenecteplase vs. Alteplase for Intravenous Thrombolytic Therapy of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
by: Ziyi Shen, et al.
Published: (2023-08-01)
by: Ziyi Shen, et al.
Published: (2023-08-01)
Reversal of ischemic cortical blindness with tenecteplase
by: Rui Tang, et al.
Published: (2025-12-01)
by: Rui Tang, et al.
Published: (2025-12-01)
Tenecteplase—What Have We Learned till Now? A Narrative Review
by: Matija Zupan, et al.
Published: (2025-08-01)
by: Matija Zupan, et al.
Published: (2025-08-01)
Opinion: can we bust the fear of symptomatic intracerebral hemorrhage due to tPA?
by: Adalia H. Jun-O'Connell
Published: (2024-09-01)
by: Adalia H. Jun-O'Connell
Published: (2024-09-01)
Successful use of intra venous tenecteplase for acute ischemic stroke in pregnancy
by: Balamurugan Namasivayam, et al.
Published: (2024-09-01)
by: Balamurugan Namasivayam, et al.
Published: (2024-09-01)
Risk of angioedema and thrombolytic therapy among stroke patients: An analysis of data from the FDA Adverse Event Reporting System database
by: Hunong Xiang, et al.
Published: (2025-01-01)
by: Hunong Xiang, et al.
Published: (2025-01-01)
In Silico Study of Different Thrombolytic Agents for Fibrinolysis in Acute Ischemic Stroke
by: Yilin Yang, et al.
Published: (2023-02-01)
by: Yilin Yang, et al.
Published: (2023-02-01)
Tenecteplase or Alteplase Better in Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion: A Single Center Observational Study
by: Agnete Teivane, et al.
Published: (2022-08-01)
by: Agnete Teivane, et al.
Published: (2022-08-01)
Endovascular thrombectomy and intravenous alteplase for acute ischaemic stroke
by: Zhuoling An
Published: (2023-09-01)
by: Zhuoling An
Published: (2023-09-01)
Efficacy of Intravenous Tenecteplase Bridge Thrombectomy for Recurrent Ischemic Stroke Within 3 Months: A Case Report
by: Liu C, et al.
Published: (2025-02-01)
by: Liu C, et al.
Published: (2025-02-01)
Tenecteplase in Ischemic Stroke: Challenge and Opportunity
by: Li G, et al.
Published: (2022-05-01)
by: Li G, et al.
Published: (2022-05-01)
Severe orolingual angioedema leading to intubation after tenecteplase administration
by: Haider Al-Hakeem, et al.
Published: (2024-09-01)
by: Haider Al-Hakeem, et al.
Published: (2024-09-01)
Dissolving porcine and human microthrombi by short exposure to microdoses of alteplase in an in vitro model of microvascular obstruction
by: Anastasia Milusev, et al.
Published: (2025-05-01)
by: Anastasia Milusev, et al.
Published: (2025-05-01)
Effect of Intravenous Thrombolytic Dose of Alteplase on Long-Term Prognosis in Patients with Acute Ischemic Stroke
by: Mingfeng Zhai, et al.
Published: (2023-05-01)
by: Mingfeng Zhai, et al.
Published: (2023-05-01)
Tenecteplase in Pulmonary Embolism Patients: A Meta-Analysis and Systematic Review
by: Zhu Zhang, et al.
Published: (2022-03-01)
by: Zhu Zhang, et al.
Published: (2022-03-01)
Effect of Time Delay on Reperfusion After Tenecteplase in an Extended Time Window: Analysis From the CHABLIS‐T Trials
by: Lan Hong, et al.
Published: (2025-06-01)
by: Lan Hong, et al.
Published: (2025-06-01)
Tenecteplase Improves Door‐to‐Needle Time in Real‐World Acute Stroke Treatment
by: Jillian Hall, et al.
Published: (2021-11-01)
by: Jillian Hall, et al.
Published: (2021-11-01)
Thrombolysis for acute ischaemic stroke with tenecteplase in a developing country: challenges and experience from a prospective observational study
by: Neeraj Basantani, et al.
Published: (2024-12-01)
by: Neeraj Basantani, et al.
Published: (2024-12-01)
Similar Items
-
Tenecteplase compared to alteplase in real-world outcome: A Swedish Stroke Register study
by: Mikael Skärlund, et al.
Published: (2024-10-01) -
CLINICAL RESULTS OF THROMBOLYTIC THERAPY WITH ALTEPLASE AND TENECTEPLASE IN PATIENTS WITH MYOCARDIAL INFARCTION
by: L. A. Bondarenko, et al.
Published: (2015-12-01) -
Comprehensive Review of Tenecteplase for Thrombolysis in Acute Ischemic Stroke
by: Liyuan Wang, et al.
Published: (2024-05-01) -
Tenecteplase and alteplase for thrombolysis of acute ischemic stroke within 4.5 hours: An efficacy and safety study
by: Nikita Dhar, et al.
Published: (2022-01-01) -
Comparative effectiveness and safety of tenecteplase versus alteplase for intravenous thrombolysis in acute ischemic stroke: a retrospective study
by: Weili Zhao, et al.
Published: (2025-10-01)
